Yu‐Ming Cheng

732 total citations
27 papers, 538 citations indexed

About

Yu‐Ming Cheng is a scholar working on Epidemiology, Hepatology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Yu‐Ming Cheng has authored 27 papers receiving a total of 538 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Epidemiology, 10 papers in Hepatology and 9 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Yu‐Ming Cheng's work include Liver Disease Diagnosis and Treatment (16 papers), Diet, Metabolism, and Disease (8 papers) and Alcohol Consumption and Health Effects (6 papers). Yu‐Ming Cheng is often cited by papers focused on Liver Disease Diagnosis and Treatment (16 papers), Diet, Metabolism, and Disease (8 papers) and Alcohol Consumption and Health Effects (6 papers). Yu‐Ming Cheng collaborates with scholars based in Taiwan, United States and China. Yu‐Ming Cheng's co-authors include Zhenghong Yuan, Zhiao Chen, Chia‐Chi Wang, Yunwen Hu, Jia‐Horng Kao, Bisheng Shi, Min Wu, Xiaonan Zhang, Sen Wang and Jieliang Chen and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Medicine.

In The Last Decade

Yu‐Ming Cheng

26 papers receiving 519 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yu‐Ming Cheng Taiwan	11	356	200	157	62	53	27	538
Wei‐Liang Liu Taiwan	13	79 0.2×	72 0.4×	72 0.5×	88 1.4×	94 1.8×	37	414
Federico Storni Switzerland	10	95 0.3×	85 0.4×	106 0.7×	38 0.6×	51 1.0×	31	448
Samir Ali Denmark	14	384 1.1×	488 2.4×	86 0.5×	315 5.1×	222 4.2×	37	915
Doo Hyun Kim South Korea	10	186 0.5×	127 0.6×	37 0.2×	21 0.3×	61 1.2×	26	296
Julien Lemaire Belgium	14	91 0.3×	72 0.4×	60 0.4×	18 0.3×	133 2.5×	20	561
Toshinori Furukawa Japan	9	165 0.5×	225 1.1×	37 0.2×	45 0.7×	143 2.7×	27	625
Simon H. Bridge United Kingdom	14	320 0.9×	278 1.4×	85 0.5×	137 2.2×	147 2.8×	33	669
Anjali Singh India	14	139 0.4×	47 0.2×	246 1.6×	231 3.7×	102 1.9×	60	636

Countries citing papers authored by Yu‐Ming Cheng

Since Specialization

Citations

This map shows the geographic impact of Yu‐Ming Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐Ming Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐Ming Cheng more than expected).

Fields of papers citing papers by Yu‐Ming Cheng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu‐Ming Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐Ming Cheng. The network helps show where Yu‐Ming Cheng may publish in the future.

Co-authorship network of co-authors of Yu‐Ming Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Yu‐Ming Cheng. A scholar is included among the top collaborators of Yu‐Ming Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu‐Ming Cheng. Yu‐Ming Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Shaowen, C. H. Wang, Yu‐Ming Cheng, et al.. (2025). Liver and atherosclerotic risk of alcohol consumption in patients with metabolic dysfunction-associated Steatotic Liver Disease. Atherosclerosis. 403. 119161–119161. 1 indexed citations

Wang, Shaowen, C. H. Wang, Yu‐Ming Cheng, et al.. (2025). Genetic predisposition of metabolic dysfunction-associated steatotic liver disease: a population-based genome-wide association study. Hepatology International. 19(2). 415–427. 4 indexed citations

Cheng, Yu‐Ming & Chia‐Chi Wang. (2024). Achieving global uniformity for the new name and diagnostic criteria of non-alcoholic fatty liver disease. Journal of the Formosan Medical Association. 123(6). 636–637. 2 indexed citations

Cheng, Yu‐Ming, Tsung‐Han Hsieh, Chia‐Chi Wang, & Jia‐Horng Kao. (2024). Overlapping group between non‐alcoholic fatty liver disease and metabolic associated fatty liver disease better for liver research. JGH Open. 8(10). 1 indexed citations

Wang, Shaowen, Tsung‐Han Hsieh, Yu‐Ming Cheng, Chia‐Chi Wang, & Jia‐Horng Kao. (2024). Liver and atherosclerotic risks of patients with cryptogenic steatotic liver disease. Hepatology International. 18(3). 943–951. 3 indexed citations

Wang, Shaowen, Yuwen Chang, C. H. Wang, et al.. (2024). Clinical profiles and their interaction of concurrent metabolic associated steatotic liver disease and hepatitis B virus infection. World Journal of Hepatology. 16(12). 1429–1440. 2 indexed citations

Cheng, Yu‐Ming, Tsung‐Han Hsieh, Chia‐Chi Wang, & Jia‐Horng Kao. (2023). Impact of HBV infection on clinical outcomes in patients with metabolic dysfunction-associated fatty liver disease. JHEP Reports. 5(9). 100836–100836. 8 indexed citations

Wang, Shaowen, et al.. (2023). Prevalence and clinical outcomes in subtypes of metabolic associated fatty liver disease. Journal of the Formosan Medical Association. 123(1). 36–44. 10 indexed citations

Cheng, Yu‐Ming, et al.. (2023). Predictors of Liver Dysfunction After Transhepatic Arterial Chemo-embolization in Hepatocellular Carcinoma Patients. Digestive Diseases and Sciences. 68(8). 3467–3472. 2 indexed citations

10.

Cheng, Yu‐Ming, Chia‐Chi Wang, & Jia‐Horng Kao. (2022). Metabolic associated fatty liver disease better identifying patients at risk of liver and cardiovascular complications. Hepatology International. 17(2). 350–356. 22 indexed citations

11.

Cheng, Yu‐Ming, et al.. (2021). Predictors of recurrence in early hepatocellular carcinoma patients treated with surgical resection. Advances in digestive medicine. 10(1). 21–27. 2 indexed citations

12.

Cheng, Yu‐Ming, Jia‐Horng Kao, & Chia‐Chi Wang. (2021). The metabolic profiles and body composition of lean metabolic associated fatty liver disease. Hepatology International. 15(2). 405–412. 29 indexed citations

13.

Cheng, Yu‐Ming & Chia‐Chi Wang. (2020). Liver abscesso-colonic fistula following hepatic infarction: A rare complication of radiofrequency ablation for hepatocellular carcinoma. Journal of the Formosan Medical Association. 120(3). 1027–1028.

14.

Chen, Yidan, Xuan Wang, Bi Chen, et al.. (2020). TPGS-1000 exhibits potent anticancer activity for hepatocellular carcinoma in vitro and in vivo. Aging. 12(2). 1624–1642. 18 indexed citations

15.

Cheng, Yu‐Ming, et al.. (2015). Silk Gland Gene Expression during Larval-Pupal Transition in the Cotton Leaf Roller Sylepta derogata (Lepidoptera: Pyralidae). PLoS ONE. 10(9). e0136868–e0136868. 9 indexed citations

16.

Wang, Sen, Zhiao Chen, Yu‐Ming Cheng, et al.. (2013). Hepatitis B Virus Surface Antigen Selectively Inhibits TLR2 Ligand–Induced IL-12 Production in Monocytes/Macrophages by Interfering with JNK Activation. The Journal of Immunology. 190(10). 5142–5151. 129 indexed citations

17.

Cheng, Yu‐Ming, et al.. (2012). Peripheral Edema Associated With Risperidone Oral Solution. Journal of Clinical Psychopharmacology. 32(1). 128–130. 12 indexed citations

18.

Bian, Guanglin, Yu‐Ming Cheng, Zekun Wang, et al.. (2009). Whole recombinant Hansenula polymorpha expressing hepatitis B virus surface antigen (yeast-HBsAg) induces potent HBsAg-specific Th1 and Th2 immune responses. Vaccine. 28(1). 187–194. 26 indexed citations

19.

Yu, Xuelian, Yu‐Ming Cheng, Bisheng Shi, et al.. (2008). Measles Virus Infection in Adults Induces Production of IL-10 and Is Associated with Increased CD4+CD25+ Regulatory T Cells. The Journal of Immunology. 181(10). 7356–7366. 50 indexed citations

20.

Chen, Zhiao, Yu‐Ming Cheng, Yongfen Xu, et al.. (2008). Expression profiles and function of Toll-like receptors 2 and 4 in peripheral blood mononuclear cells of chronic hepatitis B patients. Clinical Immunology. 128(3). 400–408. 130 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wei‐Liang Liu Breakdown of academic impact, for papers by Federico Storni Breakdown of academic impact, for papers by Samir Ali Breakdown of academic impact, for papers by Doo Hyun Kim Breakdown of academic impact, for papers by Julien Lemaire Breakdown of academic impact, for papers by Toshinori Furukawa Breakdown of academic impact, for papers by Simon H. Bridge Breakdown of academic impact, for papers by Anjali Singh